MUTATED AMYLOID PROTEIN

WIPO Patent Application WO/2006/038729

A1

It is intended to provide a novel amyloid protein (a human mutated amyloid protein) which is useful as, for example, an antigen molecule for improving a vaccine therapy. This human mutated amyloid protein is a protein which lacks Glu at the 22-position, Ala at the 21-position or Asp at the 23-position in a normal (wild type) amyloid protein consisting of 40, 42 or 43 amino acids (Aβ1-40, Aβ1-42 or Aβ1-43) respectively.

JP2003501008	[Title of Invention] 50 Human Secreted Proteins
JP5260976	Method for producing blood coagulation factor VIII C2 domain protein
JP2007187491	ELECTRODE FOR ELECTROCHEMICAL DETECTION AND METHOD OF MANUFACTURING SAME

MORI HIROSHI (JP)
TOMIYAMA TAKAMI (JP)
SHIMADA HIROYUKI (JP)

PCT/JP2005/018896

April 13, 2006

October 06, 2005

Click for automatic bibliography generation  

MORI HIROSHI (JP)
TOMIYAMA TAKAMI (JP)
SHIMADA HIROYUKI (JP)

C12N15/09; A01K67/027; A61K31/7088; A61K38/00; A61K39/395; A61K45/00; A61K48/00; A61P25/28; A61P43/00; C07K7/06; C07K7/08; C07K14/47; C07K16/18; C12N5/07; C12N5/071; C12N5/10; C12Q1/02; G01N33/15; G01N33/50; G01N33/68

JP2003534351A	2003-11-18
US20030166558A1	2003-09-04
US20040091945A1	2004-05-13

"Alzheimer-disease-like pathology in the PDAPP mouse", NATURE, vol. 400, 1999, pages 173 - 6
NICOLL, J.A.R. ET AL.: "Neuropathology of human Alzheimer disease after immunization with amyloid- peptide: a case report", NATURE MED., vol. 9, 2003, pages 448 - 452
DEMATTOS ET AL., SCIENCE, vol. 295, 2002, pages 2264 - 7
PFEIFER, M. ET AL.: "Cerebral hemorrhage after passive anti-Aj3 immunotherapy", SCIENCE, vol. 298, 2002, pages 1379
See also references of EP 1811025A4

Nishizawa, Toshio (11-1 Minami-Aoyama 6-chom, Minato-ku Tokyo, JP)

View/Download PDF      PDF Help

Previous Patent: WATER-BASED INKS FOR INK-JET PRINTING

Next Patent: REPRESENTATION OF SHEET METAL PART MODELS